The Department and the Wellcome Trust sponsored a strategic pipeline briefing into alternatives to antibiotics in 2015. The briefing reviewed the feasibility and potential clinical impact of alternatives to antibiotics, including bacteriophages, and considered approaches that were most likely to deliver new treatments in the next 10 years. The briefing concluded that bacteriophages were possible therapeutics, but too few were being progressed.
The Government continues to invest in research into new and alternative treatments. While there has been increased investment and unprecedented levels of research collaboration on antimicrobial resistance, there are still relatively few projects looking at the use of bacteriophages.